Walmart's Strategic Investments in Symbiotic and Green Dot Highlight Diversified Portfolio

Walmart maintains significant stakes in Symbiotic (135% YTD surge) and Green Dot (9.4% decline YTD). Analysts predict moderate growth potential for Walmart with a high level of "Outperform" recommendations. The consensus view from 37 analysts sets an average target price at $110.71, with a potential upside of 6.73% from the current trading price. The average recommendation from 43 brokerage firms stands at 1.7, categorizing it as "Outperform."

Walmart Inc. (NYSE: WMT) recently disclosed that it held 15 million shares of Symbiotic Inc. (NASDAQ: SYM) and 975,000 shares of Green Dot Corporation (NYSE: GDOT) at the end of the second quarter, with these positions unchanged from the first quarter. Symbiotic, which acquired Walmart's Advanced Systems and Robotics business earlier this year, has seen its shares surge by 135% on a year-to-date basis, while Green Dot has experienced a 9.4% decline [1].

Walmart's investment in Symbiotic includes a $520 million commitment for a development program aimed at funding new fulfillment solutions for online pickup and delivery. In addition, Walmart received approximately 2.2 million Green Dot shares in 2010 as part of a commercial agreement extension [1].

Analysts predict moderate growth potential for Walmart, with a high level of "Outperform" recommendations. The consensus view from 37 analysts sets an average target price at $110.71, with a potential upside of 6.73% from the current trading price. The average recommendation from 43 brokerage firms stands at 1.7, categorizing it as "Outperform" [2].

Walmart's stock has seen significant insider selling recently, with executives and institutional investors reducing their stakes. Over the past ninety days, insiders have sold 146,112 shares worth over $14 million. Despite this, the stock has a consensus rating of "Buy" from analysts with an average target price of $106.67 [2].

Walmart's recent earnings report showed $0.61 earnings per share for the quarter, beating analysts' consensus estimates of $0.58. The company's revenue was $165.61 billion, up 2.5% compared to the same quarter last year [2].

References:
[1] https://seekingalpha.com/news/4483118-walmart-held-on-to-its-stakes-in-symbiotic-and-green-dot-through-q2
[2] https://www.marketbeat.com/instant-alerts/filing-walmart-inc-nysewmt-shares-sold-by-fayez-sarofim-co-2025-08-07/